Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
CES Medicina
versión impresa ISSN 0120-8705
Resumen
GALLON VILLEGAS, LUIS JAVIER. Breast cancer associated to BRCA 1 and 2 genetic mutations. CES Med. [online]. 2012, vol.26, n.2, pp.185-199. ISSN 0120-8705.
ABSTRACT Between 5 and 10 % of breast and ovarian cancers can be traced to an autosomal dominant mode of inheritance of hereditary mutations in a pair of genes known as BRCA 1 and BRCA 2. They explain 90 % and 50 % of hereditary breast and ovarian cancer, respectively . Women carrying a mutation in the BRCA 1 gene, have a life risk for developing breast cancer and for ovarian cancer, a higher risk of colon cancer and men have a high risk of prostatic cancer. Women having the BRCA 2 gene mutation also have the same risk to develop breast cancer but the ovarian cancer is lower (10 % at 70 years) and is characterized for a risk of 6 % of breast cancer in men. Besides there are other known causes of these hereditary syndromes, other implicated genes still to be discovered. The more renoume syndromes are Lynch II, Li-Fraumeni, Ataxia - Telangiectasia, Cowden and Bloom syndromes, etc. Currently, it is possible to convey detection of carriers of these mutations based on DNA and a complete family history, but the useful prediction of genetic tests requires a formal counseling to interpret the results
Palabras clave : Breast cancer; Genetic mutations; Prophylactic mastectomy; BRCA.